- Home
- LVO vs ASMB Comparison
LVO vs ASMB Comparison
Compare LVO & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- ASMB
- Stock Information
- Founded
- LVO 2009
- ASMB 2005
- Country
- LVO United States
- ASMB United States
- Employees
- LVO N/A
- ASMB N/A
- Industry
- LVO Restaurants
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- ASMB Health Care
- Exchange
- LVO Nasdaq
- ASMB Nasdaq
- Market Cap
- LVO 89.7M
- ASMB 106.5M
- IPO Year
- LVO N/A
- ASMB 2010
- Fundamental
- Price
- LVO $0.83
- ASMB $16.86
- Analyst Decision
- LVO Strong Buy
- ASMB Buy
- Analyst Count
- LVO 2
- ASMB 2
- Target Price
- LVO $2.75
- ASMB $35.00
- AVG Volume (30 Days)
- LVO 614.2K
- ASMB 24.2K
- Earning Date
- LVO 11-07-2024
- ASMB 11-07-2024
- Dividend Yield
- LVO N/A
- ASMB N/A
- EPS Growth
- LVO N/A
- ASMB N/A
- EPS
- LVO N/A
- ASMB N/A
- Revenue
- LVO $127,817,000.00
- ASMB $28,326,000.00
- Revenue This Year
- LVO $12.29
- ASMB $267.67
- Revenue Next Year
- LVO $13.19
- ASMB $46.15
- P/E Ratio
- LVO N/A
- ASMB N/A
- Revenue Growth
- LVO 17.10
- ASMB N/A
- 52 Week Low
- LVO $0.56
- ASMB $7.68
- 52 Week High
- LVO $2.15
- ASMB $19.93
- Technical
- Relative Strength Index (RSI)
- LVO 50.81
- ASMB 49.37
- Support Level
- LVO $0.69
- ASMB $15.92
- Resistance Level
- LVO $0.95
- ASMB $17.00
- Average True Range (ATR)
- LVO 0.09
- ASMB 0.94
- MACD
- LVO 0.04
- ASMB -0.07
- Stochastic Oscillator
- LVO 65.32
- ASMB 36.15
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.